EICHOR
● Not Yet Recruiting
Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome)
Condition: IBS, Diarrhea Predominant · Sponsor: Beijing Hospital of Traditional Chinese Medicine
About this study
This trial is a randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase III clinical trial. Its purpose is to evaluate the efficacy and safety of Changji'an Capsules in subjects with diarrhea-predominant irritable bowel syndrome (liver-qi invading spleen syndrome) after 8 weeks of treatment.
This description comes directly from the study's public registry record.
Talk to the study team
LuQing Zhao, Doctor · 01087906580 · zhaoluqing@bjzhongyi.com
Always discuss trial participation with your own doctor first.
Locations (29)
| Beijing Hospital of Traditional Chinese Medicine | Beijing, Dongcheng District, China | — |
| West China Hospital, Sichuan University | Chengdu, China | — |
| Chongqing Traditional Chinese Medicine Hospital | Chongqing, China | — |
| The First Affiliated Hospital of Guangzhou University of Chinese Medicine | Guangzhou, China | — |
| The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine | Guizhou, China | — |
| Haozhou People's Hospital | Haozhou, China | — |
| Hebei Provincial Hospital of Traditional Chinese Medicine | Hebei, China | — |
| The First Affiliated Hospital of Heilongjiang University of Chinese Medicine | Heilongjiang, China | — |
| Hubei Provincial Hospital of Traditional Chinese Medicine | Hubei, China | — |
| The Affiliated Hospital of Shandong University of Traditional Chinese Medicine | Jinan, China | — |
| Kaifeng Hospital of Traditional Chinese Medicine | Kaifeng, China | — |
| Luoyang First People's Hospital | Luoyang, China | — |
+ 17 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07610434